Lv1
90 积分 2024-09-29 加入
Pharmacologic background and clinical issue of anti-influenza drugs
3天前
已关闭
A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan
3天前
已完结
Discovery of Novel Thiophene-Based Baloxavir Derivatives as Potent Cap-Dependent Endonuclease Inhibitors for Influenza Treatment
7天前
已完结
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
7天前
已完结
Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018–2019 influenza season
7天前
已完结
Population Pharmacokinetics of Baloxavir Marboxil in Japanese Pediatric Influenza Patients
8天前
已完结
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
22天前
已完结
Baloxavir
1个月前
已关闭
A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients
1个月前
已完结
Discovery of a Macrocyclic Influenza Cap-Dependent Endonuclease Inhibitor
2个月前
已完结
皖公网安备34019202002308
